Table 2.

Association between immunocompromise groups and SARS-CoV-2 viral decay.

Hazard ratio for SARS-CoV-2 viral RNA clearance
Group	HR (95% CI)	P	aHR (95% CI)	P
None (Reference)
S-HT	0.22 (0.09–0.52)	0.0005	0.32 (0.12–0.83)	0.02
S-A	0.64 (0.34–1.22)	0.2	0.74 (0.33–1.64)	0.5
NS	0.82 (0.54–1.24)	0.4	0.92 (0.58–1.46)	0.7
Hazard ratio for SARS-CoV-2 culturable virus clearance
Group	HR (95% CI)	P	aHR (95% CI)	P
None (Reference)
S-HT	0.23 (0.11–0.48)	8.7E-5	0.27 (0.12–0.63)	0.002
S-A	0.54 (0.28–1.03)	0.06	0.53 (0.26–1.11)	0.09
NS	1.12 (0.76–1.66)	0.6	1.35 (0.89–2.06)	0.2

HR, hazard ratio; aHR, adjusted hazard ratio; CI, confidence interval.

Age, sex at birth, race, ethnicity, number of vaccinations, monoclonal use, and antiviral use were adjusted for in the multivariate models.